Seer, Inc. (SEER)

Market Cap	136.21M
Revenue (ttm)	14.61M
Net Income (ttm)	-82.66M
Shares Out	58.97M
EPS (ttm)	-1.30
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	205,901
Open	2.310
Previous Close	2.320
Day's Range	2.280 - 2.365
52-Week Range	1.510 - 2.625
Beta	1.59
Analysts	Hold
Price Target	3.00 (+29.87%)
Earnings Date	Nov 6, 2024

About SEER

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratori...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Dec 4, 2020
• Employees: 147
• Stock Exchange: NASDAQ
• Ticker Symbol: SEER
• Website: https://seer.bio

Financial Performance

In 2023, Seer, Inc.'s revenue was $16.66 million, an increase of 7.54% compared to the previous year's $15.49 million. Losses were -$86.28 million, -7.20% less than in 2022.

Analyst Forecast

According to one analyst, the rating for SEER stock is "Hold" and the 12-month stock price forecast is $3.0.

Price Target

$3.0

(29.87% upside)

Analyst Consensus: Hold